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Abstract
Congenital afibrinogenemia is a very rare inherited coagulation disorder, characterized by virtual absence of plasma
fibrinogen (factor I). There are only about 250 cases reported in the world literature [1]. We describe a case of con-
genital afibrinogenemia which presented as an antenatally detected intracranial bleed.
Case report
A preterm 29 weeks baby was born of second degree
consanguinous marriage to a 28 year old G2A1 mother
by elective lower segment caesarean section. Mother
was a known case of polycystic ovarian syndrome and
was on infertility treatment. Baby was born following
intracytoplasmic sperm insertion. She had underwent
two intracytoplasmic sperm insertions previously which
were both failures. Mother had regular antenatal check
ups. Antenatal scan at 29 weeks of gestation showed a
large isoechoic intracranial extraaxial collection causing
compression of neuroparenchyma and dilatation of the
lateral ventricle. A detailed evaluation with a fetal MRI
confirmed the finding and showed a fairly large extra
axial collection with maximum thickness of 5.7 cms
seen on the right with significant mass effect on the
ipsilateral cerebral hemisphere, brainstem and cerebellar
hemisphere. There was effacement of ipsilateral lateral
ventricle and IIIrd ventricle. Significant midline shift
was seen with most of the ipsilateral neuroparenchyma
pushed towards left causing obstructive hydrocephalus
on the left (Fig 1). The collection was homogeneously
hyperintense on T1 weighted images. The large extra
axial collection suggested hemorrhage on right side with
significant mass effect evidenced by the midline shift
and hydrocephalus
Baby was born by elective lower segment caesarean
section for fetal indication in view of possible uncal con-
ing. Baby was intubated and ventilated at birth due to
poor respiratory efforts.
On clinical examination, she had a large head with
wide fontanel. Otherwise clinical examination was unre-
markable. There was no obvious external congenital
malformations. There was no obvious external bleeding
tendency.
Neurosonogram done after birth showed a large right
sided subdural hemorrhage occupying almost the entire
right hemisphere extending to midline with gross shift of
midline to left. A Plain CT taken postnatally (after drain-
ing 50 ml of collected old bleed on day 1 showed extra-
axial collection on Rt.side with a mass effect. The brain
architecture was distorted with dilated ventricles (Fig 2)
A detailed blood investigation was done to identify the
cause. Hemoglobin done at birth was 8.2 mg/dL. C reac-
tive protein, total count, differential count and micro
ESR done did not suggest sepsis. Blood culture was
reported sterile. PT and APTT done on second day of
life was both significantly prolonged. The initial INR
was also prolonged (6.36). Platelet count was 1.3 lakhs/
cmm.
The various possibilities for bleeding diathesis were
considered and evaluated. Disseminated intravascular
coagulation and sepsis was ruled out as sepsis work was
reported negative and platelet count was normal. The
possibility of a coagulation disorder was considered in
view of the clinical profile and abnormal coagulation
profile. A fibrinogen level was done to rule out the pos-
sibility of afibrinogenemia which was reported to be
undetectable. In view of the prolonged INR and APTT
along with an undetectable Fibrinogen level, the diagno-
sis of Congenital afibrinogenemia was made.
Baby was managed with Cryoprecipitates. Packed cell
transfusion was given in view of low hemoglobin value
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following one infusion of cryoprecipitate. Values above
100 was achieved by 9 days of life and was maintained
so with alternate days of cryoprecipitate infusion. The
INR and coagulation profile transiently improved with
cryoprecipitate, to subsequently revert to the previous
prolonged state when stopped. The decision was made
to maintain fibrinogen activity above 100 mg/dL (Nor-
mal value - 200 to 400 mg/dL).
2 subdural taps were done on first and third days
respectively which drained liquefied blood. Ophthalmol-
ogy consultation on day 2 of life showed pale disc with
pale retina
Baby was ventilated for a total of 14 days and extu-
bated once clinical condition stabilized. Cryoprecipitate
was stopped from 22nd day of life to see the magnitude
of fall in fibrinogen activity. On 25th day of life, Fibrino-
gen level was detected to be 45 mg/dL. A repeat neuro-
sonogram on 25th day of life showed persistence of
subdural hematoma with pressure effect. There was
probably a fresh episode of bleeding associated with sig-
nificant mass effect. Supportive measures was given
including cryoprecipitate with which the child clinically
improved.
Child was discharged after the parents were explainted
regarding the need for strict neurodevelopmental follow
up. Child was relatively asymptomatic until 3 months of
corrected age (6 months chronological age) when she
was readmitted with one episode of right sided focal sei-
zures along with poor activity and lethargy. Clinical
examination showed raised anterior fontanelle tension.
Fibrinogen level done at the time of admission was
undetectable. Emergency CT scan showed an acute
intraparenchymal bleed in left frontal lobe measuring 5
× 4.8 cm (Fig 3). There was another peripheral bleed
adjacent to the larger bleed. Intraventricular extension
of bleed was also noted with significant midline shift.
The subdural hygroma was seen in right convexity with
Extra-axial collection with midline shift
Dilated ventricle because of flow obstruction
Figure 1 Fetal MRI, T2 weighted coronal section with a mass effect on the right side with mid-line shift to the left side because of
sub-dural bleeding.
Figure 2 Plain CT taken postnatally (after draining 50 ml of
collected old bleed on day 1). The plain CT showing extra-axial
collection on Rt.side with a mass effect. The brain architecture is
distorted with dilated ventricles.
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a maximum thickness of 1.2 cm suggestive of residual
old subdural bleed. Seizures was controlled with appro-
priate anticonvulsants. An external ventricular drainage
was done to evacuate the clot. She was given supportive
measures and cryoprecipitate and was discharged after 3
days of hospitalization. VEP and BERA done at review
at 3 months of corrected age was reported normal. Baby
had attained social smile at 5 months of corrected age.
She had partial head control at 8 months of corrected
age. Babbling was present. Child is under strict neurode-
velopmental follow up and stimulation programme.
Discussion
Congenital afibrinogenemia is transmitted by an autoso-
mal recessive gene located on chromosome 4 (q26-q28).
Partial deficiency of fibrinogen is called hypofibrinogen-
emia and is a milder disorder. Afibrinogenemia occurs
in the homozygous state while hypofibrinogenemia in
heterozygotes [2]. Congenital absence of fibrinogen (Afi-
brinogenemia) was first described in 1920 and has an
estimated incidence of 1: 1-2,000,000 [3].
Congenital afibrinogenemia patients may present with
bleeding in the newborn period manifesting as hemato-
mas from traumatic delivery. They may also present
with hemetemesis, malena or bleeding from the umbili-
cus. Other manifestations include bleeding in soft tis-
sues, mucosa and following circumcision. Despite having
totally incoagulable blood, these patients normally do
not have severe spontaneous bleeding, but the case iden-
tification is important to prevent more severe bleeding
following injuries or surgery [4]. Intracranial hemor-
rhage is a rare presentation of the condition in a
neonate. Antenatal detection of intracranial bleed is still
a rarer entity. Intracranial hemorrhage has been
described as a frequent cause of death in this disorder
[5-7].
As it is a disorder with the final substrate for forma-
tion of the clot missing, results of all screening tests
such as clotting time, PT, PTT and thrombin time are
abnormal. Platelet functions such as bleeding time,
adhesion and aggregation may also be abnormal. Diag-
nosis is evident by standard fibrinogen assays.
Afibrinogenemic patients have undetectable or nearly
undetectable levels of fibrinogen (<10 mg/dL; normal
200-400 mg/dL) by activity-based clotting assays and by
measurement of immunoreactive fibrinogen. In the
absence of consumptive coagulopathy, an unmeasurable
fibrinogen level is diagnostic of the condition [7].
Hemorrhagic symptoms in fibrinogen deficiency are
most significant when the plasma level is less than 50
mg/dl [8,9]. Fresh bleeding was noticed in our case,
when the fibrinogen fell to 45 mg/dL.
Acute hemorrhagic episodes can be treated with either
fresh frozen plasma or cryoprecipitate or fibrinogen
concentrate (Cohn fraction I). Each cryoprecipitate bag
contains 100 to 150 mg of fibrinogen, and therapy with
100 mg/kg of fibrinogen provides a hemostatic plasma
level. The half-life of fibrinogen is 2-4 days and frequent
infusions are usually not necessary. However, our
patient required frequent transfusions. There was fresh
bleeding detected on ultrasonography when cryoprecipi-
tate was stopped temporarily. Recommendations regard-
ing target levels for treating bleeding range from 30-50
mg/dL [10] to 100 mg/dL [11].
Although prophylactic treatment with regular infu-
sions of cryoprecipitate has been advocated by some,
[12] it is not recommended by others for several rea-
sons. This is based on the fact that spontaneous bleed-
ing is very rare and mild. Moreover, there is a potential
danger of acquiring infections with regular blood pro-
duct infusion. Antibodies have been reported to form
against fibrinogen with resultant thromboembolic com-
plications, particularly pulmonary embolism
Acquired hypofibrinogenemia is common in dissemi-
nated intravascular coagulation and primary fibrinolysis.
The possibility of acquired afibrinogenemia is unlikely
in our case due to its antenatal presentation. A detailed
sepsis screen done was unremarkable.
The incidence of spontaneous abortions is high in afi-
brinogenemic and hypofibrinogenemic females [13-15].
Prepartum and postpartum bleeding are relatively com-
mon, and intraabdominal bleeding from ruptured corpus
luteal cysts have been reported. We had explained
regarding a detailed evaluation of the mother for any
Fibrinogen disorders. Maternal Fibrinogen level was
reported to be within normal limits. The parents were
Figure 3 Acute left frontal bleed (At 6 months corrected age).
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not willing to do any further genetic work up. We
believe that the presence of consanguinity favours the
possibility of autosomal recessive inheritance, although a
detailed genetic work up was not possible.
Administration of regular infusions of fibrinogen is
recommended to maintain pregnancies in afibrinogene-
mic woman and to reduce the incidence of postpartum
hemorrhage [16,17]. Therapy should be initiated as early
as possible because fetal loss in the first trimester is fre-
quent. Fetal loss has occurred in some patients with
fibrinogen levels above 50 mg/dL as well; therefore, it is
recommended that levels be kept above 100 mg/dL
through out the duration of the pregnancy.
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